The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Friday, August 14, 2026

Subject of the day

ENOV

Concerning the House

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

United States · www.enovis.com

The Long Run

FY 2011–2025 · 14 years

LineLatestCAGRTrend
Revenue$2.25B+11.8%
Gross profit$990.78M+11.5%
Operating income-$775.72M+29.0%
Net income-$33.26M+28.2%
Cash from ops$217.29M+12.9%
Quotation

$25.66

+0.97 (+3.9%)

52w hi$33.32
52w lo$20.04
Vol1.02M
As ofAug 13
The Verdict

Hold

Our score -0.05

Short+0.02
Medium+0.05
Long-0.40

computed 2026-08-13

By the Numbers

Enovis Corporation

Healthcare · Medical Devices

Market cap$1.48B
Enterprise value$2.78B
Trailing P/E
Forward P/E6.33x
EV / EBITDA7.34x
P / S (ttm)0.64x
Profit margin-48.0%
Return on equity-54.1%
Revenue growth+3.2%
Earnings growth
Debt / equity92.56
Risk Metrics
Beta vs SPX1.41
Corr SPX0.43
Annual vol53.2%
Annual ret-12.4%
Sharpe-0.23
Max DD-59.4%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental-0.07
Sector+0.12
Technical+0.02
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$24.89$25.70$24.23$25.661.02M
Aug 12$24.23$24.72$23.63$24.691.14M
Aug 11$24.39$25.16$24.23$24.60887.60K
Aug 10$26.35$26.59$24.18$24.241.76M
Aug 7$25.72$26.82$24.65$26.612.06M